Article Cited by others

MINI REVIEW

Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects

Abidi Afroz

Year : 2013| Volume: 4| Issue : 4 | Page no: 230-237

   This article has been cited by
 
1 UV spectroscopy and least square matching for high throughput discrimination of taxanes in commercial formulations and compounded bags
E. Jaccoulet,C. Boughanem,L. Auduteau,P. Prognon,E. Caudron
European Journal of Pharmaceutical Sciences. 2018; 123: 143
[Pubmed]  [Google Scholar] [DOI]
2 The role of taxanes in prostate cancer: literature review
A. K. Norsov,S. A. Reva
Cancer Urology. 2018; 14(2): 130
[Pubmed]  [Google Scholar] [DOI]
3 Fluorescent dyes and probes for super-resolution microscopy of microtubules and tracheoles in living cells and tissues
Gražvydas Lukinavicius,Gyuzel Y. Mitronova,Sebastian Schnorrenberg,Alexey N. Butkevich,Hannah Barthel,Vladimir N. Belov,Stefan W. Hell
Chemical Science. 2018; 9(13): 3324
[Pubmed]  [Google Scholar] [DOI]
4 Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations
Nicholas Ekow Thomford,Kevin Dzobo,Emile Chimusa,Kerstin Andrae-Marobela,Shadreck Chirikure,Ambroise Wonkam,Collet Dandara
OMICS: A Journal of Integrative Biology. 2018; 22(6): 375
[Pubmed]  [Google Scholar] [DOI]
5 Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer
Bryan Hoang,Mark J. Ernsting,Wei-Hsin Sophia Tang,Joseph Bteich,Elijus Undzys,Taira Kiyota,Shyh-Dar Li
Cancer Letters. 2017; 410: 169
[Pubmed]  [Google Scholar] [DOI]
6 Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
Tai-Lung Cha,Tony Tong-Lin Wu,Nicholas John Vogelzang,Chao-Yuan Huang,Shu-Pin Huang,Chia-Chi Lin,Yen-Chuan Ou,See-Tong Pang,Daniel Heung-Yuan Shen,Wen-Jeng Wu,Wayne Yen-Hwa Chang
Journal of the Formosan Medical Association. 2017; 116(11): 825
[Pubmed]  [Google Scholar] [DOI]
7 Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Deepali Waghray,Qinghai Zhang
Journal of Medicinal Chemistry. 2017;
[Pubmed]  [Google Scholar] [DOI]
8 Navigating the evolving therapeutic landscape in advanced prostate cancer
E. David Crawford,Daniel Petrylak,Oliver Sartor
Urologic Oncology: Seminars and Original Investigations. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma
Ignacio Duran,Carlos Hagen,José Ángel Arranz,María Apellaniz-Ruiz,Begoña Pérez-Valderrama,Nuria Sala,Nuria Lainez,Xavier García-Del Muro,Esther Noguerón,Miguel Ángel Climent,Pablo Maroto,Albert Font,Jesús García-Donas,Enrique Gallardo,Pilar López-Criado,Aránzazu González Del Alba,María Isabel Sáez,Sergio Vázquez,Raquel Luque,Cristina Rodríguez-Antona
Pharmacogenomics. 2016; 17(5): 463
[Pubmed]  [Google Scholar] [DOI]
10 Redox-Sensitive Citronellol–Cabazitaxel Conjugate: Maintained in Vitro Cytotoxicity and Self-Assembled as Multifunctional Nanomedicine
Peng Xue,Dan Liu,Jing Wang,Na Zhang,Jiahua Zhou,Lin Li,Weiling Guo,Mengchi Sun,Xiangfei Han,Yongjun Wang
Bioconjugate Chemistry. 2016;
[Pubmed]  [Google Scholar] [DOI]
11 Early investigational tubulin inhibitors as novel cancer therapeutics
Kunal Nepali,Ritu Ojha,Hsueh-Yun Lee,Jing-Ping Liou
Expert Opinion on Investigational Drugs. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
12 Formulation of Acid-Sensitive Micelles for Delivery of Cabazitaxel into Prostate Cancer Cells
Omer Aydin,Ibrahim Youssef,Yasemin Yuksel Durmaz,Gopinath Tiruchinapally,Mohamed E. H. ElSayed
Molecular Pharmaceutics. 2016;
[Pubmed]  [Google Scholar] [DOI]
13 Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo
Guangyao Lv,Dengjun Sun,Jingwen Zhang,Xiaoxia Xie,Xiaoqiong Wu,Weishuo Fang,Jingwei Tian,Chunhong Yan,Hongbo Wang,Fenghua Fu
Acta Pharmaceutica Sinica B. 2016;
[Pubmed]  [Google Scholar] [DOI]
14 Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells
Mirjam Gerwing,Christine Jacobsen,Sergey Dyshlovoy,Jessica Hauschild,Tina Rohlfing,Christoph Oing,Simone Venz,Jan Oldenburg,Karin Oechsle,Carsten Bokemeyer,Gunhild von Amsberg,Friedemann Honecker
Journal of Cancer Research and Clinical Oncology. 2016;
[Pubmed]  [Google Scholar] [DOI]
15 Taxane anticancer agents: a patent perspective
Iwao Ojima,Brendan Lichtenthal,Siyeon Lee,Changwei Wang,Xin Wang
Expert Opinion on Therapeutic Patents. 2016; 26(1): 1
[Pubmed]  [Google Scholar] [DOI]
16 Self-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer
Bo Zhuang,Liang Du,Hongxia Xu,Xuelian Xu,Cheng Wang,Yingfang Fan,Mengyi Cong,Jiaqi Yin,Hongxia Li,Huashi Guan
International Journal of Pharmaceutics. 2016; 499(1-2): 146
[Pubmed]  [Google Scholar] [DOI]
17 Mass spectrometry in the pharmacokinetic studies of anticancer natural products
Sara Crotti,Bianca Posocco,Elena Marangon,Donato Nitti,Giuseppe Toffoli,Marco Agostini
Mass Spectrometry Reviews. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
18 Regulation of local steroidogenesis in the brain and in prostate cancer: Lessons learned from interdisciplinary collaboration
H. Bobby Fokidis,Hans H. Adomat,Geetanjali Kharmate,Elham Hosseini-Beheshti,Emma S. Guns,Kiran K. Soma
Frontiers in Neuroendocrinology. 2014;
[Pubmed]  [Google Scholar] [DOI]
19 Cell-Penetrating, Guanidinium-Rich Molecular Transporters for Overcoming Efflux-Mediated Multidrug Resistance
Jessica R. Vargas,Erika Geihe Stanzl,Nelson N. H. Teng,Paul A. Wender
Molecular Pharmaceutics. 2014; 11(8): 2553
[Pubmed]  [Google Scholar] [DOI]

 

Read this article